Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

79 та иш

Иш: Harnessing exosomes for biomarker development and therapy in hepatitis virus infection

  1. The biology <b>,</b> function <b>,</b> and biomedical applications of exosomes

    Raghu Kalluri, Valerie S. LeBleu

    Шарҳ мақола202016 иқтибос
    ABI

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Joshua A Welsh, Deborah C. I. Goberdhan, Lorraine O’Driscoll +69

    Мақола20246 иқтибос
    ABI

  3. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Clotilde Théry, Kenneth W. Witwer, Elena Aïkawa +97

    Мақола20186 иқтибос
    ABI

  4. Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases

    Tao Wan, Jiafeng Zhong, Qi Pan +3

    Мақола20223 иқтибос
    ABI

  5. Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications

    Md Nurul Huda, Md Nafiujjaman, Isaac G. Deaguero +4

    Шарҳ мақола20213 иқтибос
    ABI

  6. Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?

    Mohammad Hossein Razizadeh, Alireza Zafarani, Mahsa Taghavi-Farahabadi +3

    Шарҳ мақола20232 иқтибос
    ABI

  7. First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing

    Jancy Johnson, Sam Q. K. Law, Mozhgan Shojaee +16

    Мақола20232 иқтибос
    ABI

  8. The role of immune regulation in HBV infection and hepatocellular carcinogenesis

    Hailong Zheng, Bingchen Xu, Yiyu Fan +3

    Шарҳ мақола20252 иқтибос
    ABI

  9. Current Strategies for Exosome Cargo Loading and Targeting Delivery

    Haifeng Zeng, Shaoshen Guo, Xuancheng Ren +3

    Шарҳ мақола20232 иқтибос
    ABI

  10. HBV-miR-3 is closely related to HBV replication and strongly predictive of HBeAg seroconversion in PegIFN-α treated patients

    Zhenyu Xu, Xu Yun, Zhenyu Wu +4

    Мақола20242 иқтибос
    ABI

  11. Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review

    Yusuf M. Idres, Adi Idris, Wenqing Gao

    Шарҳ мақола20252 иқтибос
    ABI

  12. Microfluidic Devices for Manufacture of Therapeutic Extracellular Vesicles: Advances and Opportunities

    Amin Hassanzadeh‐Barforoushi, Xenia Sango, Ella L. Johnston +2

    Шарҳ мақола20252 иқтибос
    ABI

  13. Exosome-Based Drug Delivery: A Next-Generation Platform for Cancer, Infection, Neurological and Immunological Diseases, Gene Therapy and Regenerative Medicine

    Dolores R. Serrano, Francisco Juste, Brayan J. Anaya +9

    Шарҳ мақола20252 иқтибос
    ABI

  14. Exosomes in Clinical Laboratory: From Biomarker Discovery to Diagnostic Implementation

    Majdi A. Aljohani

    Шарҳ мақола20252 иқтибос
    ABI

  15. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  16. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI